ADIL

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Adial Pharmaceuticals Inc

NASDAQ | ADIL

0.37

USD

$0.00

(

0.00%

)

At Close (As of Oct 16, 2025)

$8.13M

Market Cap

-

P/E Ratio

-0.71

EPS

$1.30

52 Week High

$0.22

52 Week Low

HEALTHCARE

Sector

ADIL Chart

Recent Chart
Price Action

ADIL Technicals

Tags:

ADIL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$565
Total Revenue $0
Cost Of Revenue $565
Costof Goods And Services Sold $565
Operating Income -$8.3M
Selling General And Administrative $5.1M
Research And Development $3.2M
Operating Expenses $8.3M
Investment Income Net -
Net Interest Income $179K
Interest Income $179K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $565
Income Before Tax -$13M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$13M
Comprehensive Income Net Of Tax -
Ebit -$13M
Ebitda -$13M
Net Income -$13M

Revenue & Profitability

Earnings Performance

ADIL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $5M
Total Current Assets $4.1M
Cash And Cash Equivalents At Carrying Value $3.8M
Cash And Short Term Investments $3.8M
Inventory -
Current Net Receivables -
Total Non Current Assets $985K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $3.3K
Intangible Assets Excluding Goodwill $3.3K
Goodwill -
Investments -
Long Term Investments $982K
Short Term Investments -
Other Current Assets $308K
Other Non Current Assets -
Total Liabilities $976K
Total Current Liabilities $976K
Current Accounts Payable $250K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $726K
Other Non Current Liabilities -
Total Shareholder Equity $4.1M
Treasury Stock -
Retained Earnings -$82M
Common Stock $6.5K
Common Stock Shares Outstanding $19M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$6.9M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $565
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $7.8M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$13M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$565
Total Revenue $0
Cost Of Revenue $565
Costof Goods And Services Sold $565
Operating Income -$8.3M
Selling General And Administrative $5.1M
Research And Development $3.2M
Operating Expenses $8.3M
Investment Income Net -
Net Interest Income $179K
Interest Income $179K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $565
Income Before Tax -$13M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$13M
Comprehensive Income Net Of Tax -
Ebit -$13M
Ebitda -$13M
Net Income -$13M

ADIL News

ADIL Profile

Adial Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company headquartered in Charlottesville, Virginia, dedicated to developing novel therapies for substance use disorders, with a primary focus on alcohol use disorder. The company’s lead candidate, AD04, represents a groundbreaking approach in a largely underserved market, aiming to mitigate the pressing health challenges associated with addiction. Through its innovative pipeline and commitment to improving patient outcomes, Adial is strategically positioned to offer transformative solutions in addiction treatment and prevention, potentially reshaping the landscape of therapies available for affected individuals.

VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
BITF
-18.39%
$5.28
CGBS
-39.47%
$0.03
PLUG
-9.61%
$3.48
NVDA
+1.10%
$181.81
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.52%
$3.09
NIO
+0.14%
$6.83
MIRA
+36.36%
$1.80
F
-0.17%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
FEMY
+35.37%
$0.74
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.14%
$22.50
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.41%
$3.23
MARA
-11.27%
$20.26
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
GDXD
-10.23%
$0.60
BTG
+4.76%
$5.94
LAES
-15.08%
$6.36
BTBT
-9.11%
$3.69
GNPX
-43.39%
$0.47
RF
-5.61%
$23.35
QBTS
-9.64%
$40.46
VSEE
-13.85%
$0.51
QS
-13.38%
$15.46
RR
-7.95%
$5.67
LGCB
+19.39%
$1.97
GPUS
-5.78%
$0.36
NAK
-15.15%
$2.24
ABAT
-36.64%
$5.67
RGTZ
+29.08%
$11.23
HBAN
-5.18%
$15.37
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
BAC
-3.51%
$50.44
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
CLSK
-13.83%
$19.98
AMC
-2.48%
$2.75
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
PLTR
-0.83%
$178.12
T
+0.49%
$26.20
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
FNB
-7.21%
$14.65
SMR
-10.83%
$47.64
WTO
-88.87%
$0.13
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.53%
$5.68
ADD
-25.47%
$0.05
HIMS
-5.75%
$59.15
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
CRWV
+1.79%
$141.74
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.67%
$0.43
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
BITF
-18.39%
$5.28
CGBS
-39.47%
$0.03
PLUG
-9.61%
$3.48
NVDA
+1.10%
$181.81
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.52%
$3.09
NIO
+0.14%
$6.83
MIRA
+36.36%
$1.80
F
-0.17%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
FEMY
+35.37%
$0.74
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.14%
$22.50
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.41%
$3.23
MARA
-11.27%
$20.26
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
GDXD
-10.23%
$0.60
BTG
+4.76%
$5.94
LAES
-15.08%
$6.36
BTBT
-9.11%
$3.69
GNPX
-43.39%
$0.47
RF
-5.61%
$23.35
QBTS
-9.64%
$40.46
VSEE
-13.85%
$0.51
QS
-13.38%
$15.46
RR
-7.95%
$5.67
LGCB
+19.39%
$1.97
GPUS
-5.78%
$0.36
NAK
-15.15%
$2.24
ABAT
-36.64%
$5.67
RGTZ
+29.08%
$11.23
HBAN
-5.18%
$15.37
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
BAC
-3.51%
$50.44
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
CLSK
-13.83%
$19.98
AMC
-2.48%
$2.75
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
PLTR
-0.83%
$178.12
T
+0.49%
$26.20
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
FNB
-7.21%
$14.65
SMR
-10.83%
$47.64
WTO
-88.87%
$0.13
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.53%
$5.68
ADD
-25.47%
$0.05
HIMS
-5.75%
$59.15
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
CRWV
+1.79%
$141.74
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.67%
$0.43
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.